Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia

C. Nucera, E. Mazzon, B. Caillou, M. A. Violi, M. Moleti, C. Priolo, G. Sturniolo, D. Puzzolo, V. Cavallari, F. Trimarchi, F. Vermiglio

Research output: Contribution to journalArticle

Abstract

Human galectin-3 (hgal-3) is a β-galactoside binding protein involved in a number of physiological and pathological processes. Increasing hgal-3 immunoexpression has been reported in several human tumors, including thyroid carcinomas, but not in benign thyroid lesions. We analyzed the immunolocalization of hgal-3 in cell compartments of benign and malignant thyroid lesions. Hgal-3 immunoperoxidase reaction was carried out on 133 thyroid tissue samples obtained from 113 patients; 20 of these were normal (NT), 85 were benign thyroid lesions [20 colloid nodules (CN), 21 nodular hyperplasias (NH), 7 focal lymphocytic thyroiditis (FLT), 15 Hashimoto's thyroiditis (HT), 22 follicular adenomas (FA)], 25 differentiated carcinomas [15 papillary carcinomas (PC), 6 follicular carcinomas (FC) and 4 Hürthle cell carcinomas (HC)] and 3 anaplastic carcinomas (AC). Among the malignant thyroid lesions, hgal-3 was detected in 12/15 (80%) PC, 3/4 (75%) HC and in 4/6 (66.6%) FC, but in none of the 3 AC. Conversely, hgal-3 immunoexpression was absent in NT and in all benign thyroid lesions, but 1/15 HT and 10/22 (45.4%) FA. In the latter, hgal-3 was mostly expressed in microfollicular areas and in five of the six atypical FA. Hgal-3 cytoplasmic-perinuclear immunolocalization was observed in the majority of thyroid carcinomas and in more than half of the FA, theoretically suggesting an involvement of this protein in thyroid tumorigenesis throughout an antiapoptotic activity. Moreover, hgal-3 expression in FA might anticipate the likelihood of evolution of these benign lesions towards malignancy.

Original languageEnglish
Pages (from-to)106-112
Number of pages7
JournalJournal of Endocrinological Investigation
Volume28
Issue number2
Publication statusPublished - 2005

Keywords

  • Cell atypia
  • Cell immunolocalization
  • Follicular adenomas
  • Human galectin-3
  • Thyroid carcinomas

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia'. Together they form a unique fingerprint.

  • Cite this

    Nucera, C., Mazzon, E., Caillou, B., Violi, M. A., Moleti, M., Priolo, C., Sturniolo, G., Puzzolo, D., Cavallari, V., Trimarchi, F., & Vermiglio, F. (2005). Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia. Journal of Endocrinological Investigation, 28(2), 106-112.